tradingkey.logo

TherapeuticsMD Inc

TXMD
2.290USD
+0.100+4.57%
收盤 02/06, 16:00美東報價延遲15分鐘
26.50M總市值
87.50本益比TTM

TherapeuticsMD Inc

2.290
+0.100+4.57%

關於 TherapeuticsMD Inc 公司

TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).

TherapeuticsMD Inc簡介

公司代碼TXMD
公司名稱TherapeuticsMD Inc
上市日期Jan 31, 2001
CEOWalker (Marlan D)
員工數量1
證券類型Ordinary Share
年結日Jan 31
公司地址951 Yamato Road, Suite 220
城市BOCA RATON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編33431
電話15619611900
網址https://www.therapeuticsmd.com/
公司代碼TXMD
上市日期Jan 31, 2001
CEOWalker (Marlan D)

TherapeuticsMD Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
73.64K
--
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
73.64K
--
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
448.00K
57.14%
Non-U.S
336.00K
42.86%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Rubric Capital Management LP
10.30%
Clearline Capital LP
5.49%
The Vanguard Group, Inc.
3.43%
Tejara Capital Ltd.
3.03%
Adar1 Capital Management LLC
1.81%
其他
75.94%
持股股東
持股股東
佔比
Rubric Capital Management LP
10.30%
Clearline Capital LP
5.49%
The Vanguard Group, Inc.
3.43%
Tejara Capital Ltd.
3.03%
Adar1 Capital Management LLC
1.81%
其他
75.94%
股東類型
持股股東
佔比
Hedge Fund
18.44%
Investment Advisor
7.87%
Individual Investor
1.62%
Investment Advisor/Hedge Fund
1.39%
Research Firm
1.13%
其他
69.55%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
82
3.33M
28.78%
-21.58K
2025Q3
82
3.26M
28.17%
-348.35K
2025Q2
88
5.28M
45.63%
+1.46M
2025Q1
93
3.58M
30.94%
-393.28K
2024Q4
95
3.73M
32.32%
-2.03M
2024Q3
99
3.59M
31.15%
-463.34K
2024Q2
121
3.62M
31.37%
-2.25M
2024Q1
209
3.66M
32.13%
-802.21K
2023Q4
230
4.54M
44.12%
-1.60M
2023Q3
274
4.44M
43.31%
-158.22K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Rubric Capital Management LP
1.19M
10.3%
--
--
Sep 30, 2025
Clearline Capital LP
635.22K
5.49%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
376.83K
3.26%
-2.17K
-0.57%
Sep 30, 2025
Tejara Capital Ltd.
344.20K
2.97%
-51.00
-0.01%
Sep 30, 2025
Adar1 Capital Management LLC
209.21K
1.81%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
129.59K
1.12%
-528.00
-0.41%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
116.13K
1%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
109.08K
0.94%
--
--
Sep 30, 2025
Walker (Marlan D)
73.64K
0.64%
--
--
Oct 20, 2025
Collins (Cooper C)
60.52K
0.52%
--
--
Oct 20, 2025
查看更多

持股ETF

更新時間: 12月2日 週二
更新時間: 12月2日 週二
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
公告日期
除權除息日
類型
比率
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
KeyAI